Zoetis Inc. Treasury Stock, Shares, Acquired
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- Zoetis Inc. treasury stock, shares, acquired for the quarter ending 2026-03-31 was 12.30M shares.
- Zoetis Inc. treasury stock, shares, acquired for the quarter ending 2019-12-31 was -2.60M shares.
- Zoetis Inc. treasury stock, shares, acquired for the quarter ending 2019-09-30 was 1.30M shares, a 21.21% decline year-over-year.
- Zoetis Inc. treasury stock, shares, acquired for the quarter ending 2019-06-30 was 1.44M shares, a 43.53% decline year-over-year.
- Zoetis Inc. treasury stock, shares, acquired for fiscal 2025 was 300.00K shares, a 50.00% decline from fiscal 2024.
- Zoetis Inc. treasury stock, shares, acquired for fiscal 2024 was 600.00K shares, a 33.33% decline from fiscal 2023.
- Zoetis Inc. treasury stock, shares, acquired for fiscal 2023 was 900.00K shares, a 28.57% increase from fiscal 2022.
- Zoetis Inc. treasury stock, shares, acquired for fiscal 2022 was 700.00K shares, a 46.15% decline from fiscal 2021.
| Period end | Treasury Stock, Shares, Acquired 3 month | Treasury Stock, Shares, Acquired 12 month |
|---|---|---|
| 2026-03-31 | 12.30M shares 10-Q · filed 2026-08-06 | |
| 2025-12-31 | 300.00K shares 10-K · filed 2026-02-12 | |
| 2024-12-31 | 600.00K shares 10-K · filed 2026-02-12 | |
| 2023-12-31 | 900.00K shares 10-K · filed 2026-02-12 | |
| 2022-12-31 | 700.00K shares 10-K · filed 2025-02-13 | |
| 2021-12-31 | 1.30M shares 10-K · filed 2024-02-13 | |
| 2020-12-31 | 1.60M shares 10-K · filed 2023-02-14 | |
| 2019-12-31 | -2.60M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | 1.80M shares 10-K · filed 2022-02-15 |
| 2019-09-30 | 1.30M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -460.00K shares derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-06-30 | 1.44M shares 10-Q · filed 2019-08-06 | -110.00K shares derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-03-31 | 1.70M shares 10-Q · filed 2020-05-06 | 1.00M shares derived: sum of 4 quarters · filed 2021-02-16 |
| 2018-12-31 | -4.90M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | 1.70M shares 10-K · filed 2021-02-16 |
| 2018-09-30 | 1.65M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | |
| 2018-06-30 | 2.55M shares 10-Q · filed 2019-08-06 | |
| 2017-12-31 | 1.60M shares 10-K · filed 2020-02-13 | |
| 2016-12-31 | 1.72M shares 10-K · filed 2019-02-14 | |
| 2015-12-31 | 57.27K shares 10-K · filed 2018-02-15 | |
| 2015-06-28 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | 21.74K shares derived: sum of 4 quarters · filed 2017-02-16 |
| 2015-03-29 | 20.00K shares 10-Q · filed 2016-05-06 | 27.74K shares derived: sum of 4 quarters · filed 2017-02-16 |
| 2014-12-31 | 743.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | 14.74K shares 10-K · filed 2017-02-16 |
| 2014-09-28 | 1.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | |
| 2014-06-29 | 6.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | |
| 2014-03-30 | 7.00K shares 10-Q · filed 2015-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |